INTENSIVE CHEMOTHERAPY WITH HIGH-DOSES OF BCNU, ETOPOSIDE, CYTOSINE-ARABINOSIDE, AND MELPHALAN (BEAM) FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION - TOXICITY AND ANTITUMOR-ACTIVITY IN 26 PATIENTS WITH POOR-RISK MALIGNANCIES

被引：53

作者：

GASPARD, MH

MARANINCHI, D

STOPPA, AM

GASTAUT, JA

MICHEL, G

TUBIANA, N

BLAISE, D

NOVAKOVITCH, G

ROSSI, JF

WEILLER, PJ

SAINTY, D

HORCHOWSKI, N

CARCASSONNE, Y

机构：

[1] INST PAOLI CALMETTES,INSERM,U119,MALAD SANG CLIN,MARROW TRANSPLANT UNIT,232 BD STE MARGUERITE,F-13273 MARSEILLE 9,FRANCE

[2] CHU TIMONE,PEDIAT UNIT,F-13385 MARSEILLE,FRANCE

[3] CTR HOSP AVIGNON,AVIGNON,FRANCE

[4] CTR TRANSFUS SANGUINES,BLOOD BANK,MARSEILLE,FRANCE

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1988年 / 22卷 / 03期

关键词：

D O I：

10.1007/BF00273421

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：256 / 262

页数：7

共 45 条

[1]

ANDERSON CC, 1986, CANCER CHEMOTH PHARM, V16, P170

[2]

APPELBAUM FR, 1978, CANCER, V41, P1059, DOI 10.1002/1097-0142(197803)41:3<1059::AID-CNCR2820410339>3.0.CO

[3]

2-N

[4] REVIEW OF THE USE OF MARROW TRANSPLANTATION IN THE TREATMENT OF NON-HODGKINS LYMPHOMA [J].

APPELBAUM, FR ;

THOMAS, ED .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (07) :440-447

[5]

BONADONNA G, 1982, CANCER RES, V42, P4309

[6]

CABANILLAS F, 1982, BLOOD, V60, P693

[7]

CARELLA AM, 1984, CANCER, V54, P2836, DOI 10.1002/1097-0142(19841215)54:12<2836::AID-CNCR2820541203>3.0.CO

[8]

2-R

[9]

CARTER S K, 1976, Cancer Treatment Reports, V60, P807

[10] INTENSIVE AND SEQUENTIAL COMBINATION CHEMOTHERAPY FOR AGGRESSIVE MALIGNANT-LYMPHOMAS (PROTOCOL LNH-80) [J].

COIFFIER, B ;

BRYON, PA ;

BERGER, F ;

ARCHIMBAUD, E ;

FFRENCH, M ;

EXTRA, JM ;

GUYOTAT, D ;

FIERE, D ;

GENTILHOMME, O ;

MAGAUD, JP ;

BLANC, M ;

PEAUD, PY ;

VUVAN, H ;

VIALA, JJ .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :147-153

← 1 2 3 4 5 →